New tiny implants destroy brain cancer cells

Glioblastoma is one of the toughest brain cancers to treat, but researchers at MIT’s Media Lab have unveiled a striking new approach. They’ve created nanoantennas, tiny structures about one‑hundredth the width of a human hair, that can be injected directly into the brain. Once inside, these antennas can be magnetically activated to generate highly localized electric fields.

The beauty of this technique is precision: the fields are strong enough to kill glioblastoma cells, yet gentle enough to spare healthy brain tissue. The team calls the technology HITMAN (short for highly localized electric field–induced tumor therapy using magnetically actuated nanoantennas).

Unlike conventional treatments, HITMAN is wireless, targeted, and cellular‑level accurate, offering a potential breakthrough in tackling one of the deadliest cancers.

Deblina Sarkar, associate professor and AT&T Career Development Chair at the MIT Media Lab, said, “In laboratory and animal studies, this approach significantly reduced tumor growth and extended survival without detectable side effects, highlighting its potential as a precise and safe brain cancer therapy.”

Scientists created the world’s tiniest antenna using DNA

To test it against the most realistic form of glioblastoma, the team used patient‑derived tumor tissue from Mayo Clinic, specifically aggressive, chemotherapy‑resistant GBM. In lab experiments, HITMAN wiped out 52.2% of these drug‑resistant cells, more than five times the effect of temozolomide (TMZ), the standard chemotherapy drug, while leaving healthy neurons and astrocytes untouched.

They then used orthotopic mouse models, which are the gold standard in brain tumor research, by placing patient-derived cells into the mouse brains. HITMAN considerably reduced tumor growth and increased median survival by more than 50%, with no toxicity that could be detected in the major organs or in the surrounding tissue.

The system operates wirelessly; after the nanoantennas have been injected, an external low-frequency magnetic field (200 kHz or less) passes through the skull and into the brain tissue.

Within the antennas, the magnetostrictive elements react to the field by generating stress and strain. This causes a deformation of a piezoelectric film, as a result of which local electric fields are produced that selectively destroy GBM cells.

It’s a striking demonstration of how bioelectric therapy could open a new frontier in cancer treatment: precise, wireless, and minimally invasive.

The localized electric fields generated by HITMAN nanoantennas were shown to disrupt glioblastoma cells at the cellular level by interfering with the bioelectric currents that regulate normal function.

This disruption triggered multiple antitumor mechanisms, including protein unfolding, membrane damage, and endoplasmic reticulum stress, ultimately leading to cell death.

It is important that the cancer cells were selectively targeted since their rapid growth increases the demand for protein folding and the fact that their membranes and organelles are abnormal, whereas the healthy neurons and astrocytes were left unharmed.

The results of the control experiments showed that the effect was caused by the combination of the nanoantennas and magnetic activation, and not by the antennas on their own or by the magnetic field alone. In the animal models, no toxicity was found in the major organs.

Moreover, the treatment reduced the number of cancer cell colonies from 112 to 150 in the control groups down to just 26, indicating a great potential for limiting recurrence and metastasis.

For the future, the nanoantennas, which measure 150 nanometres in size, could be injected directly into the skull. Even more promising is a related technology known as circulatronics, which was developed in 2025 and which might enable delivery through a simple injection into the arm, crossing the blood-brain barrier without causing immune rejection.

This is especially significant because glioblastoma is notoriously difficult to treat: it infiltrates brain tissue, resists chemo and radiotherapy, and evades immunotherapy. HITMAN offers a radically different, wireless bioelectric approach that could one day change the outlook for patients facing this devastating cancer.

Journal Reference:

1. Monochura Saha, Ishaq N. Khan, Baju Joy, Shun-Ying Chen, Hao-Tung Yang, Preet Patel et al. Magnetically actuated nanoantennas for wireless glioblastoma therapy. Science Advances. DOI: 10.1126/sciadv.aeb1237